Virtual Velocity

CMEA Capital is trying its hand at virtual development with newco Velocity Pharmaceutical Development LLC.

Velocity plans to acquire early stage candidates, ensconce each in a company structure without an associated staff, develop them through proof-of-concept data and then sell them. Velocity expects to conduct clinical development of individual candidates in less than three and a half years for less than $15 million...